Institute of HIV Research and Innovation

What Institute of HIV Research and Innovation does

The Institute of HIV Research and Innovation (IHRI) is a Thailand-based non-profit organization founded in 2002, headquartered in Bangkok, and operating across Southeast Asia. Its mandate spans HIV research, clinical work, and professional development in healthcare, with a headcount in the 11–50 range. The organization runs public-health and harm-reduction programming rather than a commercial product portfolio; its most recently documented initiative is the Chemsafe campaign, launched in collaboration with House Of TayTay on 2025-11-30 to address the harms of chemsex in Thailand through storytelling and podcast episodes that promote de-stigmatization of drug use and sexual-health issues.

IHRI's operational model is that of a mission-driven non-profit: it does not sell a product, has no disclosed pricing or API, and generates no documented commercial revenue. Its primary 'customers' in the user-experience sense are individuals in Thailand affected by chemsex and sexual-health issues, while its funding base — implicit for a non-profit — is not disclosed in the available source data. The Chemsafe campaign illustrates IHRI's content-led, narrative-based approach to harm reduction, deliberately differentiated from abstinence-only messaging, and points to partnerships with cultural/community organizations as a core go-to-market mechanism.

Strategically, IHRI is navigating a difficult funding environment: the Chemsafe value proposition explicitly cites the need to counter declining HIV prevention funding across the Asia-Pacific region. With no disclosed grants, contracts, or fundraising rounds in the input, IHRI's financial scale and growth direction cannot be triangulated with precision. The available evidence supports characterizing IHRI as a small, specialized, community-engaged non-profit whose near-term strategic lever is programmatic partnerships rather than commercial expansion.

Name

Institute of HIV Research and Innovation

Legal name

Institute of HIV Research and Innovation

Website

https://ihri.org

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Institute of HIV Research and Innovation (IHRI) is a Bangkok-based non-profit founded in 2002 that conducts HIV research and runs harm-reduction public-health campaigns in Thailand, including the Chemsafe storytelling and podcast initiative addressing chemsex-related harms.

Ownership category

akta.pro rank

Product category

HIV Research and Public Health Services

NAICS

Scientific Research and Development Services (5417)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAJAMAJ

Monitoring, Evaluation, Performance Management & Quality Improvement

Healthcare & Life Sciences/Public Health, Government & Regulators/Public Health Policy & Administration

SECONDARYBPADAIAH

Health Security, Pandemic Preparedness & Response (IHR, EID)

Business & Public Services/International Organizations & Development/Global Health & Population Programs

Keywords

• HIV research
• Harm reduction
• Sexual health
• Public health campaigns
• Chemsex prevention

Headquarters

HQ city

Bangkok

HQ country

Thailand

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Marketing channels1 record

Core offering

Institute of HIV Research and Innovation (IHRI) is a Thailand-based non-profit organization conducting HIV research, clinical work, and professional development in healthcare. Its primary evidenced initiative is the Chemsafe campaign, developed in collaboration with House Of TayTay, which uses storytelling and podcast episodes to deliver harm reduction messaging and de-stigmatize drug use and sexual health issues in Thailand.

Product overview

The Institute of HIV Research and Innovation (IHRI) is a research organization focused on HIV prevention and public health initiatives. Based on available source data, IHRI operates public health campaigns and harm reduction programs rather than a technology product portfolio. The primary initiative identified is the Chemsafe campaign, a collaboration with House Of TayTay in Thailand aimed at addressing chemsex-related harms through storytelling and podcast-based harm reduction approaches. No specific digital products, platforms, or software offerings are documented in the accessible source material.

Differentiator

Problem solved

Functional benefit

Products and services

• Chemsafe Campaign

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• House Of TayTaymoderateStrategic or Co-development Partner · 30 November 2025Collaboration between House Of TayTay and IHRI on the Chemsafe campaign, launched in Thailand to address the harms of chemsex. The partnership utilizes storytelling and podcast episodes to promote harm reduction and de-stigmatize drug use and sexual health issues, aiming to foster open conversations and provide support for affected individuals.

Recent moves1 record

Expansion highlights4 records

Direct peers

• Aidsfonds: Dutch-based non-profit funding HIV prevention, care, and harm-reduction programs for key populations globally; closely comparable to IHRI for its community-led, harm-reduction intervention model.
• Frontline AIDS: International non-profit alliance supporting community-led HIV prevention, treatment, and harm reduction with key populations; closely comparable to IHRI's NGO-led, community-engagement HIV intervention model.
• APCOM Foundation: Asia-Pacific non-profit working on HIV, sexual health, and rights among MSM and key populations; directly comparable to IHRI's regional Thailand-based harm-reduction and sexual-health focus.
• AVAC (Global Advocacy for HIV Prevention): Non-profit focused on HIV prevention advocacy, research translation, and program delivery globally; closely comparable to IHRI's HIV research and public-health-intervention orientation.

Broad incumbents

• UNAIDS: UN-coordinated global HIV/AIDS program administering funding, policy, and technical guidance; comparable to IHRI as a key player in HIV prevention program delivery in Thailand and the wider Asia-Pacific.
• Population Services International (PSI): Large global health non-profit delivering HIV prevention, sexual and reproductive health programs in developing markets; comparable to IHRI for harm-reduction and behavior-change campaign delivery.
• amfAR (Foundation for AIDS Research): One of the world's leading HIV/AIDS research non-profits; directly comparable to IHRI as a research-driven organization focused on HIV prevention, treatment, and education, though operating at a much larger global scale.
• FHI 360: Global non-profit running large-scale HIV prevention, research, and public-health programs across multiple countries; comparable to IHRI for HIV research and community-based intervention delivery.

Regional players

• Thai Red Cross AIDS Research Centre: Thailand-based HIV research and clinical care organization; comparable to IHRI given shared geography, HIV research focus, and clinical/community outreach activities.
• TREAT Asia / amfAR: Regional Asia-Pacific HIV research network under amfAR; comparable to IHRI for its HIV research and clinical collaboration across Southeast Asia.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights4 records

Customer concentration

• Xx.com/ihriofficial

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute of HIV Research and Innovation